|
2015
|
Invention
|
Human binding molecules capable of binding to and neutralizing influenza b viruses and uses there... |
|
|
Invention
|
Vaccine against rsv.
Described is a vaccine against respiratory syncytial virus (RSV), comprisin... |
|
|
Invention
|
Vaccine against rsv.
Provided is a vaccine against respiratory syncytial virus (RSV), comprising... |
|
2014
|
Invention
|
Improved formulations for virosomes. The present invention provides virosome formulations, in par... |
|
|
Invention
|
Process for preparing influenza vaccines. The present invention provides a novel process for test... |
|
|
Invention
|
Acellular pertussis vaccine.
Described are acellular pertussis (aP) vaccine compositions compris... |
|
|
Invention
|
Method for the clarification of high density crude cell culture harvest. The invention provides m... |
|
|
Invention
|
Adenovirus formulations. The present invention provides pharmaceutical adenovirus formulations, i... |
|
|
Invention
|
Improved adenovirus formulations. The present invention provides pharmaceutical adenovirus formul... |
|
|
Invention
|
Complementing cell lines. A packaging cell line that complements recombinant adenoviruses based o... |
|
|
Invention
|
Method for preparing virosomes.
Described are methods for preparing virosomes comprising the ste... |
|
|
Invention
|
Method for preparing virosomes. The present invention provides novel and improved methods for pre... |
|
|
Invention
|
Method for preparing virosomes. The present invention relates to methods for preparing a virosome... |
|
|
Invention
|
Stabilized soluble pre-fusion rsv f polypeptides. The present invention provides stable pre-fusio... |
|
|
Invention
|
Therapeutic vaccination against active tuberculosis.
The invention provides a method for therape... |
|
|
Invention
|
Anti-human respiratory syncytial virus (rsv) antibodies and methods of use. Provided herein are a... |
|
|
Invention
|
Influenza virus vaccines and uses thereof. The present invention provides influenza hemagglutinin... |
|
|
Invention
|
Pneumatic alternating pressure membrane cell separation system.
Described are filtration systems... |
|
|
Invention
|
Production of poliovirus at high titers for vaccine production. 6 cells/ml, and c) harvesting pol... |
|
|
Invention
|
Stabilized soluble prefusion rsv f polypeptides. The present invention provides stable pre-fusion... |
|
|
Invention
|
Human antibodies binding to rsv g protein. The invention relates to isolated antibodies and antig... |
|
|
Invention
|
Human antibodies binding to rsv g proteins. The invention provides isolated antibodies and antige... |
|
|
Invention
|
Acellular pertussis vaccine. The invention relates to an acellular pertussis (aP) vaccine composi... |
|
|
Invention
|
Acellular pertussis vaccine. pertussis toxoid (PT), filamentous hemagglutinin (FHA), and fimbriae... |
|
2013
|
Invention
|
Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof. Described ... |
|
|
Invention
|
Human binding molecules capable of binding to and neutralizing hepatitis b viruses and uses there... |
|
|
Invention
|
Antibodies against human respiratory syncytial virus (rsv) and methods of use. Provided herein ar... |
|
|
Invention
|
Adenoviral vectors for transduction of vascular tissue. The invention relates to the field of gen... |
|
|
Invention
|
Vaccine against rsv. Provided is a vaccine against respiratory syncytial virus (RSV), comprising ... |
|
|
Invention
|
Vaccine against rsv. The invention provides a vaccine against respiratory syncytial virus (RSV), ... |
|
|
Invention
|
Production of poliovirus at high titers for vaccine production.
Described is a process for produ... |
|
|
Invention
|
Batches of recombinant adenovirus with altered terminal ends. Described is a composition comprisi... |
|
|
Invention
|
Batches of recombinant adenovirus with altered terminal ends. The invention provides a compositio... |
|
|
Invention
|
Vaccination against influenza.
Described are methods for vaccinating a subject against influenza... |
|
|
Invention
|
Improved vaccination against influenza. The invention provides methods for vaccinating against in... |
|
2012
|
Invention
|
Heterologous prime-boost immunization using measles virus-based vaccines. The invention provides ... |
|
|
Invention
|
Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and p... |
|
|
Invention
|
Complementing cell lines.
A packaging cell line that complements recombinant adenoviruses based ... |
|
|
Invention
|
Pneumatic alternating pressure membrane cell separation system. Provided are filtration systems t... |
|
2011
|
Invention
|
Therapeutic vaccination against active tuberculosis. Mycobactium tuberculosis (Mtb). Advantageous... |
|
|
Invention
|
Heterologous prime boost vaccination regimen against malaria. P. falciparum, the method comprisin... |
|
2010
|
G/S
|
Pharmaceutical and veterinary products namely vaccines and therapeutic proteins for the preventio... |
